HALOZYME THERAPEUTICS, INC.
SEC Filing List
HALO CIK: 0001159036
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | Torley Helen | Halozyme Therapeutics, Inc. | 04/07/2026 | |
| 4 | Statement of changes in beneficial owner... | Ramsay David A | Halozyme Therapeutics, Inc. | 04/02/2026 | |
| 4 | Statement of changes in beneficial owner... | Torley Helen | Halozyme Therapeutics, Inc. | 04/02/2026 | |
| SCHEDULE 13G/A | 03/27/2026 | ||||
| DEF 14A | Definitive proxy statements | Halozyme Therapeutics, Inc. | 03/23/2026 | ||
| DEFA14A | Definitive additional proxy soliciting m... | Halozyme Therapeutics, Inc. | 03/23/2026 | ||
| ARS | Annual report to security holders | Halozyme Therapeutics, Inc. | 03/23/2026 | ||
| 3 | Initial statement of beneficial ownershi... | Ramsay David A | Halozyme Therapeutics, Inc. | 03/23/2026 | |
| 8-K | Current report filing | Halozyme Therapeutics, Inc. | 03/12/2026 | ||
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 03/10/2026 | ||
| No record found. | |||||
| Load More | |||||
